| Page 653 | Kisaco Research
 

Robert Molander

CCO
Infant Bacterial Therapeutics

Robert has over 25 years of experience working in life science organizations with launching and commercializing pharmaceuticals in the United States at organizations such as Pfizer and Novartis. He has also served as an Executive Council Member at the Harvard Medical School. Robert holds an MBA from Washington University and bachelor’s degrees from Miami University in Economics and International Studies.

Read full bio

Robert Molander

CCO
Infant Bacterial Therapeutics

Robert Molander

CCO
Infant Bacterial Therapeutics

Robert has over 25 years of experience working in life science organizations with launching and commercializing pharmaceuticals in the United States at organizations such as Pfizer and Novartis. He has also served as an Executive Council Member at the Harvard Medical School. Robert holds an MBA from Washington University and bachelor’s degrees from Miami University in Economics and International Studies.

Agenda

Hello

Technology Companies

Hello

Animal Nutrition Companies

Hello

Multinationals

  1. Align your company's strategy current market needs, trends, and keep an eye on the latest acquisitions and regulations within the industry through our consumer-focused sessions and roundtables
  2. Bolster your product portfolio and streamline your production process through partnerships with our audience of multinational Animal Health and Technology companies, actively seeking the right collaborators that match their objectives
  3. Identify potential partners who match your needs and mission from our attendee network of over 150 emerging compani